Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 30 EP applications Andrea Josephine Strang has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 11, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13711952

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/4188, C07D 487/04, A61P 35/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13734183

PYRROLOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/407, C07D 487/04, A61P 35/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP13814360

PYRIDONE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF TUBERCULOSIS

IPC classification:
A61K 31/4412, C07D 405/06, C07D 401/06, C07D 213/64, A61P 31/06
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP14703441

SUBSTITUTED PURINONE COMPOUNDS

IPC classification:
C07D 473/28
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP14704909

PYRAZOLO[3,4-D]PYRIMIDINONE COMPOUNDS AS INHIBITORS OF THE P53/MDM2 INTERACTION

IPC classification:
A61K 31/519, C07D 487/04, A61P 35/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP14708992

BENZOTHIOPHENE DERIVATIVES AND COMPOSITIONS THEREOF AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS

IPC classification:
A61P 35/00, A61K 31/381, C07D 417/12, C07D 413/12, C07D 413/04, C07D 409/12, C07D 409/10, C07D 409/04, C07D 333/66, C07D 333/64
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14728350

PYRAZOLO-PYRROLIDIN-4-ONE DERIVATIVES AS BET INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61P 35/00, A61K 31/4162, A61K 31/437, C07D 519/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP14731799

PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61P 35/00, A61K 31/4162, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP14741368

PYRAZOLO-PYRROLIDIN-4-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61P 3/00, A61P 31/00, A61P 35/00, A61K 31/4439, A61K 31/444, A61K 31/506, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP14731798

IMIDAZOPYRROLIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61P 35/00, A61K 31/4188, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP16161001

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61P 35/00, A61K 31/4188, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14812645

PYRROLOPYRROLONE DERIVATIVES AND THEIR USE AS BET INHIBITORS

IPC classification:
A61P 35/00, A61K 31/407, C07D 519/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15703106

1 -(TRIAZIN-3-YI_/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61P 35/04, A61K 31/495, C07D 241/26, C07D 249/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP15703105

1 -PYRIDAZIN-/TRIAZIN-3-YL-PIPER(-AZINE)/IDINE/PYROLIDINE DERIVATIVES AND AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61K 31/4965, A61K 31/505, C07D 249/14, C07D 241/26, C07D 239/48
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP15703321

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61P 35/04, A61K 31/495, C07D 241/20, C07D 241/18
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP15766661

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

IPC classification:
A61P 35/00, A61K 31/501, C07D 305/06, C07D 405/12, C07D 405/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP15766660

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

IPC classification:
A61P 35/00, A61K 31/5377, C07D 413/04, C07D 213/74, C07D 413/14, C07D 403/12
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP17182338

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61P 35/00, A61K 31/4188, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP17191365

CHOLINE SALT OF AN ANTI-INFLAMMATORY SUBSTITUTED CYCLOBUTENEDIONE COMPOUND

IPC classification:
A61P 29/00, A61K 31/18, C07C 311/48, C07C 215/40
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The application has been published
EP16731341

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61P 25/28, A61P 21/00, A61P 19/00, A61P 9/00, A61P 35/00, A61K 31/519, C07D 519/00, C07D 487/04, C07D 471/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP16731665

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61P 25/28, A61P 21/00, A61P 19/00, A61P 9/00, A61P 35/00, A61K 31/4545, A61K 31/513, A61K 31/537, C07D 491/107, C07D 401/14, C07D 401/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP16731666

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61P 25/28, A61P 21/00, A61P 19/00, A61P 9/00, A61P 35/00, A61K 31/537, A61K 31/506, C07D 498/10, C07D 491/107, C07D 471/10, C07D 401/04, C07D 401/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP18156411

BENZOTHIOPHENE DERIVATIVES AND COMPOSITIONS THEREOF AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS

IPC classification:
A61P 35/00, A61K 31/381, C07D 417/12, C07D 413/12, C07D 413/04, C07D 409/12, C07D 409/10, C07D 409/04, C07D 333/66, C07D 333/64
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The application has been published
EP18173244

IMIDAZOPYRROLIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4162, C07D 498/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The application has been published
EP17705425

TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS

IPC classification:
A61P 31/12, A61K 31/4745, C07D 491/14, C07D 217/08
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP17710061

CYANO-SUBSTITUTED INDOLE COMPOUNDS AND USES THEREOF AS LSD1 INHIBITORS

IPC classification:
A61P 35/00, A61K 31/404, C07D 209/14, C07D 405/06, C07D 405/04, C07D 403/04, C07D 401/06, C07D 401/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP17733041

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61P 35/00, A61P 9/00, C07D 519/00, C07D 513/04, C07D 487/04, C07D 403/14, C07D 401/14, A61K 31/4545, C07D 471/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP17814686

CRYSTALLINE FORMS OF TRIAZOLOPYRIMIDINE COMPOUND

IPC classification:
A61P 35/00, A61K 31/519, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP17733536

IMIDAZOPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/02, A61K 31/519, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP17733529

TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF

IPC classification:
A61P 35/00, A61K 31/437, C07D 471/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made

Please Sign in to use this feature